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We recently demonstrated that lymph nodes (LNs) PD-1+/T follicular helper (Tfh) cells 
from antiretroviral therapy (ART)-treated HIV-infected individuals were enriched in cells 
containing replication competent virus. However, the distribution of cells containing 
inducible replication competent virus has been only partially elucidated in blood memory 
CD4 T-cell populations including the Tfh cell counterpart circulating in blood (cTfh). 
In this context, we have investigated the distribution of (1) total HIV-infected cells and 
(2) cells containing replication competent and infectious virus within various blood and 
LN memory CD4 T-cell populations of conventional antiretroviral therapy (cART)-treated 
HIV-infected individuals. In the present study, we show that blood CXCR3-expressing 
memory CD4 T  cells are enriched in cells containing inducible replication competent 
virus and contributed the most to the total pool of cells containing replication competent 
and infectious virus in blood. Interestingly, subsequent proviral sequence analysis did 
not indicate virus compartmentalization between blood and LN CD4 T-cell populations, 
suggesting dynamic interchanges between the two compartments. We then investi-
gated whether the composition of blood HIV reservoir may reflect the polarization of LN 
CD4 T cells at the time of reservoir seeding and showed that LN PD-1+ CD4 T cells of 
viremic untreated HIV-infected individuals expressed significantly higher levels of CXCR3 
as compared to CCR4 and/or CCR6, suggesting that blood CXCR3-expressing CD4 
T cells may originate from LN PD-1+ CD4 T cells. Taken together, these results indicate 
that blood CXCR3-expressing CD4 T cells represent the major blood compartment con-
taining inducible replication competent virus in treated aviremic HIV-infected individuals.
Keywords: T follicular helper cells, replication competent virus, circulating T follicular helper cell counterpart, 
cXcr3, lymph node
Abbreviations: ART, antiretroviral therapy; LNs, lymph nodes; cART, conventional antiretroviral therapy; Tfh, T follicular 
helper.
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inTrODUcTiOn
Antiretroviral therapy (ART)-treated HIV-infected individuals 
interrupting treatment experience HIV viremia rebound within 
2–3  weeks (1, 2), demonstrating that HIV persists despite 
therapy and that conventional antiretroviral therapy (cART) 
does not cure HIV in its actual setting. One of the main mecha-
nisms by which HIV persists is attributed to the ability of the 
virus to infect activated CD4 T cells entering a quiescent state 
(3), thereby establishing a latent HIV cell reservoir (4). Latently 
HIV-infected CD4 T  cells are transcriptionally silent and are 
therefore not targeted by cART or by the immune system (5). 
As a direct consequence, infected CD4 T cells containing HIV 
DNA are detectable in virtually all ART-treated HIV-infected 
individuals (6). Since, ART does not target HIV-infected cells, 
it has been estimated, based on the half life of memory CD4 
T cells, that as long as 70 years of ART might be required for the 
eradication of the latent reservoir (4). Moreover, mechanisms 
such as homeostatic proliferation may also contribute to further 
increase the stability of the latent HIV reservoir (3, 4, 7, 8).
The composition of the latent HIV reservoir is complex and 
different cell subsets may contribute such as CD4 T cells, mono-
cytes and macrophages (8–10). Among the CD4 T-cell subsets, 
central memory (CM; defined by CD45RA–CCR7+CD27+) 
and transitional memory (TM; CD45RA–CCR7–CD27+) CD4 
T cells were identified as major CD4 T-cell populations con-
tributing the most to the latent HIV-1 reservoir in blood (7). 
Additional CD4 T-cell populations enriched in cells contain-
ing replication competent viruses were later described such as 
memory CD4 T cells with stem-cell like properties (11). On 
the same line, Descours et al. identified CD32a (low-affinity 
receptor for the immunoglobulin G Fc fragment) as a specific 
marker of latently HIV-infected quiescent CD4 T  cells (12). 
However, lymphocytes reside predominantly within lymphoid 
organs while blood contains only 2% of the total body’s 
lymphocytes. More importantly, lymphocyte populations 
within the tissues are phenotypically and functionally distinct 
from those in blood (13). The recently described T follicular 
helper (Tfh) cells illustrate this difference (14, 15). In this 
regard, lymph nodes (LN) memory Tfh cells and to a lesser 
extent memory CXCR5−PD-1+ CD4 T  cells were previously 
shown to serve as the major CD4 T-cell compartments for 
HIV replication, production and infection in viremic HIV-
1-infected individuals (16). In addition, we have recently 
demonstrated that LN PD-1+/Tfh CD4 T  cells isolated from 
ART-treated aviremic HIV-infected individuals were enriched 
in cells containing replication competent and infectious HIV 
as compared to any other PD-1 negative memory CD4 T-cell 
populations isolated from blood or LN (17). This phenomenon 
is probably associated with the limited cytotoxic CD8 T-cell 
access to germinal centers (GCs) (18, 19) where infected Tfh 
cells locate. However, since HIV-infected effector Tfh cells 
surviving viral cytopathic effects and escaping extra-follicular 
CD8 T-cell mediated clearance may convert to memory CD4 
T  cells and recirculate in blood (20, 21), we hypothesized 
that blood circulating Tfh cell counterpart (circulating Tfh or 
cTfh) may therefore be enriched in cells containing replication 
competent virus.
Circulating Tfh (cTfh) cells were initially defined by the expres-
sion of CXCR5 and showed enhanced capacity to provide naïve 
and memory B-cell help (22). Later, cTfh cells were subdivided 
into various subsets based on the expression of CXCR3, CCR4, 
CCR6, PD-1, and ICOS (23–25). Indeed, T-cell migration is 
orchestrated by the combination of cell-adhesion molecule and 
chemokine receptor expression (20) Notably, CXCR5 expression 
allows cell migration to B cell follicles, CXCR3 expression allows 
cell migration to inflamed tissues and CCR4 and CCR6 expression 
allows migration to skin and mucosal tissues, respectively (26, 27).
In this context, we have investigated the distribution of 
replication competent and infectious virus within differ-
ent blood memory CD4 T-cell populations identified on 
the basis of their migratory potential determined by the 
chemokine receptor expression and compared to memory 
CD4 T-cell populations isolated from LNs of cART-treated 
HIV-infected individuals. Briefly, blood circulating memory 
(CD45RA−) CD4 T-cell populations were identified on the 
basis of expression of CXCR3, CXCR5, CCR4, and CCR6, 
i.e., CXCR3+CXCR5− (CXCR3+), CCR4+CCR6− (CCR4+), 
CCR4+CCR6+, CXCR3−CXCR5+, and CXCR3+CXCR5+ CD4 
T cells, the latter two populations corresponding to “cTfh” (22, 
23) and “Th1-like cTfh” (28). On the other hand, LN memory 
(CD45RA−) CD4 T-cell populations were identified on the 
basis of the expression of CXCR5 and/or PD-1 expression as 
previously described (17).
In the present study, we show that blood CXCR3-expressing 
but not CXCR5-expressing memory CD4 T-cell subset was 
significantly enriched in cells containing inducible replication 
competent virus and contributed the maximum to the total pool 
of cells containing replication competent and infectious virus in 
blood. However, the enrichment of blood CXCR3-expressing 
memory CD4 T  cells with cells containing replication compe-
tent virus was not associated with increased level of activation, 
HIV coreceptor expression or reduced HIV restriction factor 
expression, nor with an enrichment in cells harboring central or 
transitional memory phenotype.
To determine whether blood CXCR3-expressing memory 
CD4 T cells containing replication competent virus may originate 
from LN Tfh cells, proviral EnvV1-V4 sequences of blood and LN 
CD4 T-cell populations of ART-treated aviremic HIV-infected 
individuals were analyzed but did not indicate virus compart-
mentalization. We then investigated whether the composition 
of blood HIV reservoir may reflect the polarization of LN CD4 
T cells at the time of reservoir seeding and showed that LN PD-1+/
Tfh cells of viremic untreated HIV-infected individuals expressed 
significantly higher levels of CXCR3 as compared to CCR4 and/
or CCR6 which is consistent with previous studies performed in 
chronically SIV-infected macaques (29).
Taken together, these results indicate that blood CXCR3-
expressing CD4 T cells represent the major blood compartment 
containing inducible replication competent virus in treated 
aviremic HIV-infected individuals. However, additional studies 
would be needed to determine their potential origins and the 
TaBle 1 | Characteristics of study group.
subject iD Duration of hiV  
infection (years)
cD4 count  
(cells/μl)a
Viral load  
(copies/ml)a








#10 9.1 543 <20 8.8 EFV, 3TC INT DNA, VOA, FC NA
#12 8.4 453 <20 2.9 3TC/r, ABC INT DNA, VOA, FC NA
#14 10.1 1,691 <20 3.5 EFV, TDF, FTC INT DNA, VOA, FC INT DNA, VOA
#16 25.9 487 <20 2 ETR; DRV/r; RAL INT DNA, VOA, FC NA
#18 2.6 376 <20 2.5 FTC, TDF, EFV INT DNA, VOA, FC NA
#20 25.3 480 <20 14.1 ETR, DRV/r, RAL INT DNA, VOA, FC NA
#26 9.6 666 <20 2 3TC, ABC, DTG INT DNA, VOA, FC INT DNA, VOA
#35 2.1 1,219 <20 1.8 FTC, TDF, EVG INT DNA, SEQ, VOA, FC INT DNA, SEQ, VOA
#43 2.8 605 <20 2.8 3TC, ABC, DTG VOA, FC NA
#45 8 442 <20 7.9 FTC, TDF, ETR INT DNA, VOA, FC NA
#75 4.7 417 <20 3.2 FTC, TDF, EFV INT DNA, VOA VOA
#94 7 440 <20 6.9 FTC, TDF, EVG INT DNA, SEQ, VOA VOA, SEQ
#107 1.9 598 <20 1.8 FTC, TDF, EFV INT DNA, VOA VOA
#077 6.6 560 <20 6 3TC, ABC, DTG SEQ SEQ
#24 10.7 629 <20 3.9 FTC, TDF, EFV NA INT DNA, VOA
#11 16.2 811 <20 11.7 FTC, TDF, ATV/r NA INT DNA, VOA
#04 2.9 424 <20 1.8 EFV, TDF, FTC NA INT DNA, VOA
#25 28.5 439 <20 4.6 FTC, TDF, RAL NA INT DNA, VOA
#42 11.1 949 <20 6.6 FTC, TDF, ATV/r NA INT DNA, VOA
#106 0.1 501 160,000 0 NA NA MC
#140 0.08 427 360,000 0 NA NA MC
#119 1.3 498 13,000 0 NA NA MC
#124 0.06 468 510,000 0 NA NA MC
#113 31.98 594 640 0 NA NA MC
#117 5.42 504 54,000 0 NA NA MC
#125 0.16 511 17,000 0 NA NA MC
#118 0.06 538 14,000 0 NA NA MC
#SA150 10 578 6,900 0 NA NA MC
aCD4 cell count and viral load assessments are at the time of enrollment in the study.
ETR, Etravirine; FTC, Emtricitabine; TDF, Tenofovir disoproxil fumarate; ATV/r, Atazanavir boosted with ritonavir; 3TC, Lamivudine; ABC, Abacavir; DRV/r, Darunavir boosted with 
ritonavir; EFV, Efavirenz; RAL, Raltegravir; DTG, Dolutegravir; EVG, Elvitegravir; LN, lymph node; INT DNA, integrated DNA; VOA, viral outgrowth assay; FC, flow cytometry; SEQ, 
sequencing; MC, Mass cytometry; NA, not applicable.
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The present study was approved by the Institutional Review Board 
of the Centre Hospitalier Universitaire Vaudois, and all subjects 
gave written informed consent.
study group and cell isolation
Nine viremic untreated HIV-1-infected adult volunteers and 19 
aviremic ART-treated HIV-infected individuals were enrolled 
in the present study (Table  1). No predetermined statistical 
analysis was performed for sample size and was estimated based 
on a previously published study (17). As inclusion criteria only 
patients under ART for atleast 12  months with undetectable 
HIV-1 viremia (<20 HIV-1 RNA copies/mL) were enrolled. As 
exclusion criteria, individuals experiencing blips of viremia (>50 
HIV-1 RNA copies/mL of plasma) within the last 12 months were 
not enrolled. Leukapheresis and blood samples were obtained at 
the local blood bank (Centre de transfusion sanguine (CTS), 
Lausanne, Switzerland). Blood mononuclear cells were isolated 
as previously described (30).
reagents and cell culture
Cells were cultured in RPMI (Gibco; Life Technologies) contain-
ing 10% heat-inactivated fetal bovine serum (FBS; Institut de 
Biotechnologies Jacques Boy), 100 IU/mL penicillin, and 100 µg/
mL streptomycin (Bio Concept).
antibodies
The following antibodies were used: APC-H7-conjugated anti-
CD3 (clone SK7), PB or FITC or PE-CF594-conjugated anti-CD4, 
PerCP-Cy5.5-conjugated anti-CD8 (clone SK1), (clone RPA-T4), 
(2G8), PE-conjugated anti-CCR6 (11A9), PE-Cy7-conjugated 
anti-CCR4 (1G1), V450-conjugated anti-HLA-DR (clone G46-6), 
PE-Cy7-conjugated anti-CD25 (clone M-A251), PeCy5-conjugated 
anti-CXCR4 (12G5), AlexaFluor700-conjugated anti-CCR5 
(HEK/1/85a), PB or PeCy7 conjugated anti-PD-1 (EH12.1), anti-
CCR7 (2H4), AlexaFluor700-conjugated anti-CD27 (M-T271), 
PE-conjugated anti-Ki67 (B56) purified coating anti-CD3 (clone 
UCHT1) and anti-CD28 (clone CD28.2) mAbs were purchased 
from BD (Becton Dickinson, San Diego CA, USA). PB-conjugated 
anti-CXCR3 (1C6) and PE or APC or PerCP-eFluor710-conjugated 
anti-CXCR5 mAbs were all purchased from Biolegend (Switzerland). 
ECD-conjugated anti-CD45RA (clone 2H4) was purchased from 
Beckman Coulter (Brea CA, USA) and anti-SAMHD1 (611-625) 
was purchased from Thermo Scientific (Switzerland).
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sorting of Blood and ln Memory cD4 
T-cell Populations
Sorting of chemokine-receptor-expressing memory CD4 T cells 
was performed using FACS Aria as previously described (17). 
Briefly, cryopreserved blood mononuclear cells were thawed 
and CD4 T  cells were enriched using EasySep Human CD4 
T-cell enrichment kit (StemCell Technologies, Cambridge 
MA, USA). CD4 T  cells were then stained with Aqua LIVE/
DEAD stain kit (4°C; 15  min) and then to simultaneously 
investigate the expression of chemokine receptors on CD4 
T  cell membrane, with anti-CD3 APCH7, anti-CD4 FITC, 
anti-CD45RA ECD, anti-CXCR3 PB, anti-CXCR5 APC, anti-
CCR4 PE-Cy7 and anti-CCR6 PE (4°C; 25  min). Viable CD4 
memory (CD45RA−) CXCR3+CXCR5−, CXCR3−CXCR5+, 
CXCR3+CXCR5+, CXCR3−CXCR5−CCR4+CCR6−, and CXCR3− 
CXCR5−CCR4+CCR6+ T-cell populations were then sorted. In 
parallel, cryopreserved LN mononuclear cells were also thawed 
and stained with Aqua LIVE/DEAD stain kit (4°C; 15 min) and 
then with anti-CD3 APCH7, anti-CD4 FITC, anti-CD45RA 
ECD, anti-PD-1 PE-Cy7, and anti-CXCR5 APC (at 4°C; 25 min) 
and viable CD4 memory (CD45RA−) CXCR5−PD-1− (DN), 
CXCR5+PD-1− (single CXCR5), and total PD-1+ cells were sorted. 
The grade of purity of the sorted cell populations was >97% in all 
sorting experiments.
integrated hiV-1 Dna Quantification
Blood and LN memory CD4 T cells of ART-treated HIV-infected 
individuals were sorted and CD3 gene copy numbers were 
determined as previously described (31). The frequency of HIV-1 
integrated DNA per million of cells was then calculated as previ-
ously described (31).
Viral Outgrowth assay
Multiple cell concentrations, i.e., fivefold limiting dilutions: 
5 × 105, 105, 2 × 104, and 4 × 103 for blood CD4 T cell populations 
and 105, 2 × 104, and 4 × 103 for LN CD4 T-cell populations of 
sorted viable blood and LN memory CD4 T cells isolated from 
ART-treated HIV-infected individuals were cultured with allo-
genic fresh CD8-depleted blood mononuclear cells (106  cells/
mL) from HIV-uninfected individuals in the presence of anti-
CD3/anti-CD28 MAb coated plates (10 µg/mL) for 3 days. Cells 
were then carefully transferred to new uncoated plates post 3 
full days of activation. All conditions were cultured in complete 
RPMI supplemented with IL-2 (50  units/mL) for 14  days. 
Medium was replenished at day 5, and re-supplemented with 
cytokines. Supernatants were collected at day 14. The presence 
of HIV-1 RNA was assessed by COBAS® AmpliPrep/TaqMan® 
HIV-1 Test (Roche; Switzerland). Wells with detectable HIV-1 
RNA (≥20 HIV-1 RNA copies/mL) were referred to as HIV-1 
RNA-positive wells. RUPM frequencies (32) were estimated 
by conventional limiting dilution methods using Extreme 
Limiting Dilu tion analysis (http://bioinf.wehi.edu.au/software/
elda/) (33). The esti mation of each population’s contribution to 
the overall pool of HIV-infected cells within blood compart-
ment or within LN compartment was performed as previously 
described (17) (Table S1 in Supplementary Material). Briefly, 
estimated contribution of memory CD4 T  cell population 
A from blood or LN to the pool of cells containing replica-
tion competent virus in blood or LN compartments =  [(% of 
memory CD4 T cell population A from compartment X among 
total memory CD4 T cells from compartment X) × (estimated 
RUPM freq. of memory CD4 T cell population A from compart-
ment X)] × [% of the estimated number of memory CD4 T cells 
present in compartment A among the sum of the memory CD4 
T cells present in blood or LN]/[(sum of absolute values of cells 
containing replication competent virus within each memory 
CD4 T cell population) × 100]. In addition, estimated contribu-
tion of memory CD4 T  cell population A from compartment 
X to the pool of cells containing replication competent virus 
in both blood and LN compartments =  [(% of memory CD4 
T cell population A from compartment X among total memory 
CD4 T cells from compartment X) × (estimated RUPM freq. of 
memory CD4 T cell population A from compartment X)] × [% 
of the estimated number of memory CD4 T  cells present in 
compartment A among the sum of the memory CD4 T  cells 
present in both blood and LN]/[(sum of absolute values of cells 
containing replication competent virus within each memory 
CD4 T cell population from compartment X and Y) × 100]. The 
estimated number of total blood and LN memory CD4 T cells 
was obtained from Ganusov et al. (34).
In Vitro hiV-1 infection assay
The in  vitro infection assay was performed as previously des-
cribed (17). Briefly, preactivated CD8-depleted blood mono-
nuclear cells isolated from HIV-uninfected individuals were 
washed and exposed for 6 h at 37°C to 100 µl of VOA super-
natants (obtained from the highest concentration, i.e., 5 × 105) 
collected at day 14 from all chemokine receptor expressing 
blood memory CD4 T-cell populations in VOA. Following 6 h 
exposure, cells were washed twice with complete medium and 
cultured for 14 additional days in complete RPMI medium. The 
presence of infectious HIV-1 particles was determined in culture 
supernatants at day 0 and 14 post inoculations as assessed by 
HIV-1 RNA assay (COBAS® AmpliPrep/TaqMan® HIV-1 Test) 
as previously described (17). For this assessment of HIV RNA, 
all samples were prediluted 1/10 in basematrix buffer (RUWAG 
Handels AG).
Proviral sequencing of env V1-V4 region
Proviral sequencing of Env V1-V4 was performed on three 
aviremic ART-treated HIV-infected individuals (Table  1). 
No predetermined criteria was used to choose patients for 
phylogenetic sequencing. RNA or DNA was extracted using 
Qiagen kit QIAAMP DSP VIRUS KIT or AllPrep DNA/RNA, 
respectively, according to manufacturer’s instructions. Fifteen 
microliters of RNA and DNA (equal to 100,000 cells) were 
used as input for the first step PCR using SuperScript III RT/
Platinum or and Taq High Fidelity Enzyme Mix (Invitrogen). 
RNA was reverse transcribed using the reverse primer Rev-
7659-86 5′ TGGAGAAGTGAATTATATAAATATAAAG [Hxb2 
7659←7686]. The 1st round PCR was performed in a 50 µl reac-
tion (0.5 µl (= 5U) High Fidelity Platinum Taq (Life technologies, 
Darmstadt), 3.5 mM MgCl2, 4 µl of dNTPs and (2.0 mM of each) 
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forward For6435-67 5′ ACACATGCCTGTGTACCCACAGACC 
CCAACCCA) [Hxb2 6435→6467] and reverse Rev7659-86 
primers, at 95°C for 10 min followed by 45 cycles (94°C-30 s, 
55°C-30 s, 68°C-3 min) and 7 min at 68°C. The 2nd round PCR 
was performed with 5 µl of first round PCR product in a 50 µl 
reaction using the same conditions and the primers For6540-62 
5′GAGGATATAATCAGTTTATGGGA [Hxb2 6540→6562] 
and Rev7647-68 5′CACTTCTCCAATTGTCCCTCAT [Hxb2 
7647←7668]. To the nested primers were extended with tags 
that conferred unique identification codes to each plasma or 
cell fraction. Tagged amplified products were purified using 
the Ampure beads (Angencourt). Following assessment of 
DNA concentration (Nanodrop and Qubit) and fragments size 
(Fragment Analyser, AAT) amplicons were pooled on an equi-
molar basis. The ends of the DNA were repaired as described by 
Pacific Bioscience prior to generation of the SMRTbell library 
(SMRTbell library kit, Pacific Bioscience), which was then 
purified, quantified and analyzed for fragment size. The library 
was annealed to sequencing primers at values predetermined 
by the Binding Calculator (PacBio) and a complex made with 
the DNA Polymerase (P6/C4 chemistry). The complex was 
bound to Magbeads and used to set up the required number 
of SMRT cells for the project. Sequencing was performed using 
360-min movie times on the Pacific Biosciences RS11 instru-
ment. Consensus sequences from PacBio reads were generated 
with accepting only reads where the DNA template had been 
read at least three times to ensure high quality. All reads were 
blasted against HIV and converted into fasta files. The resulting 
sequences were de-multiplexed according to the tags associated 
with each subcellular fraction and clustered upon 97% identity 
to exclude differences introduced during PCR amplification. 
An average of 2,600 reads was obtained ranging between 600 
and 5,300 reads. The phylogenetic relationship was inferred by 
the Maximum Likelihood method based on the General Time 
Reversible substitution model (GTR +  G) and the nucleotide 
variation within or between plasma and cellular virus pools was 
estimated using the Gama distributed kimura-two-parameter 
model and the Mega software package.
accession number(s)
Sequences were submitted to GenBank under accession numbers 
MG755825-MG756598.
assessment of T-cell activation Marker, 
hiV coreceptor and restriction Factor 
expression by Flow cytometry
Cryopreserved blood mononuclear cells from ART-treated 
HIV-1-infected individuals were thawed and stained with Aqua 
LIVE/DEAD stain kit (4°C; 15  min) and then with anti-CD3, 
anti-CD4, anti-CD45RA, anti-CXCR3, anti-CXCR5, anti-CCR4, 
anti-CCR6 PE, anti-HLA DR, anti-Ki67, anti-CD27, anti-CCR7, 
anti-CCR5 and anti-CXCR4 antibodies (4°C; 25 min). Regarding 
SAMHD1 staining, blood mononuclear cells were surface stained 
with Aqua LIVE/DEAD stain kit (4°C; 15  min) and then with 
anti-CD3, anti-CD4, anti-CD45RA, anti-CXCR3, anti-CXCR5, 
anti-CCR4, anti-CCR6 PE. Cells were then permeabilized 
(Fixation/Permeabilization Kit; BD; 45 min; 4°C) and incubated 
with anti-SAMHD1 (4°C; 25  min) antibody and then with a 
PE-conjugated donkey-antirabbit antibody (4°C; 25 min). Cells 
were then washed and acquired on LSRII SORP.
Flow cytometry
Data were acquired on a LSR SORP four lasers (405, 488, 
532, and 633 nm) and were analyzed as previously described 
(17, 35).
Mass cytometry
Mass cytometry experiments were performed as previously 
described (17). Briefly, cryopreserved LN mononuclear cells 
isolated from viremic untreated HIV-infected individuals were 
thawed and resuspended (106 cells/mL) in complete RPMI 
medium. Cell viability was assessed using cisplatin (50  µM; 
5 min at RT; Sigma-Aldrich) quenched with fetal bovine serum. 
Cells were then incubated (30 min; 4°C) with metal conjugated 
antibodies, i.e., anti-CD3-170, anti-CD4-115, anti-CD8-145, 
anti-CD45RA-169, anti-CXCR5-153, anti-CXCR3-154, anti-
CCR6-141, and anti-CCR4-149 (Fluidigm/DVS Science), 
washed and fixed (10 min; RT) with 2.4% PFA. Total cells were 
identified by DNA intercalation (1  µM Cell-ID Intercalator, 
Fluidigm/DVS Science) in 2% PFA at 4°C overnight. Labeled 
samples were assessed by the CyTOF1 instrument that was 
upgraded to CyTOF2 (Fluidigm) using a flow rate of 0.045 mL/
min. Data were analyzed as previously described (17).
statistical analyses
Statistical significance (P-values) was either obtained using 
two-tailed Chi-square analysis for comparison of positive 
proportions or using one-way ANOVA (Kruskal–Wallis test) 
followed by Wilcoxon matched-pairs two-tailed signed rank 
test as previously described (17, 35). Extreme limiting dilu-
tion analysis was applied to obtain statistics for frequencies 
of cells containing replication competent virus as in previous 
studies (1, 7, 35). Statistical significance for contribution 
analysis were either obtained from pairwise comparisons of 
proportion with FDR correction (multiple tests) or from fisher 
exact test for pairwise comparisons in case of small sample 
size. When required, Bonferroni’s correction was applied for 
multiple comparisons. Finally, Spearman rank test was used 
for correlations.
resUlTs
In the present study, 9 viremic HIV-infected individuals and 19 
aviremic ART-treated HIV-infected individuals were enrolled. 
LN biopsies were collected for all nine viremic HIV-infected 
individuals. Among the aviremic ART-treated individuals, 12 LN 
biopsies and 14 leukapheresis samples were collected, amongst 
which 7 individuals were matched for blood and LNs (Table 1). 
The 19 subjects studied had a documented duration of HIV-1 
infection between 1.9 and 28.5 years (mean 10.1 years), a dura-
tion of ART between 1.8 and 14  years (mean 4.99  years) and 
viremia levels <20 HIV-1 RNA copies/mL of plasma for at least 
12 months (Table 1).
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characterization of cD4 T cell 
Populations
The expression of chemokine receptors was first assessed in blood 
memory CD4 T  cells isolated from aviremic ART-treated indi-
viduals by multiparametric flow cytometry. To address this issue, 
blood mononuclear cells were stained with CD3, CD4, CD45RA, 
CXCR5, CXCR3, CCR4, and CCR6. In parallel, LN mononuclear 
cells were stained with CD3, CD4, CD45RA, CXCR5, and PD-1 
antibodies. Five populations of blood memory (CD45RA−) CD4 
T cells were identified on the basis of chemokine receptor expres-
sion, i.e., CXCR3+CXCR5− (CXCR3+), CXCR3−CXCR5−CCR4+C 
CR6− (CCR4+), CXCR3−CXCR5−CCR4+CCR6+, CXCR3− 
CXCR5+ (circulating Tfh-like cells; cTfh) (22, 23), and CXCR3+ 
CXCR5+ (Th1-like cTfh cells) (28) T cells (Figure 1A; Figure S1 
in Supplementary Material). The expression of CCR4 and coex-
pression of CCR4 and CCR6 was also assessed on the remaining 
CXCR3+, cTfh and Th1-like cTfh cells (Figure S2 in Supplementary 
Material) and revealed no significant differences between the 
subpopulations (P > 0.05).
Lymph node CD4 T-cell populations were identified on the 
basis of CXCR5 and PD-1 expression. Because of the very low 
percentage of PD-1+ CD4 T cells in LNs, it was not possible to 
sort individual PD-1+ cell populations and therefore we sorted for 
the total PD-1+ CD4 T cell population, CXCR5+PD-1−, i.e., single 
CXCR5+ cells and the CXCR5−PD−1− dual negative cells (DN) 
cells as previously described (Figure  1B). Of note, PD-1+ cells 
coexpressing CXCR5 represented 61% of the total LN PD-1+ CD4 
T cell population and were therefore referred to as LN PD-1+/Tfh 
cells (Figure 1C).
Quantification of integrated hiV-1  
Dna in sorted Blood and ln  
cD4 T-cell Populations
In order to determine the contribution of each CD4 T-cell sub-
set to the pool of HIV-1-infected cells, the percentage of each 
blood and LN CD4 T cell population on memory (CD45RA−) 
CD4 T cells and the frequency HIV-1-infected cells containing 
integrated HIV-1 DNA in blood and LN were determined. In 
blood, CCR4+ and CXCR3+ CD4 T cell subsets represented the 
majority, i.e., up to 29 and 22% of the memory CD4 T  cells, 
respectively (Figure  1D) followed by cTfh CD4 T  cells that 
represented 13.7% and finally CCR4+CCR6+ and Th1-like cTfh 
CD4 T-cell subsets that represented 8.9 and 8.7% of the memory 
CD4 T cells, respectively. Regarding the LN compartment, LN 
DN memory CD4 T  cell subset represented up to 50% of the 
LN memory CD4 T  cells followed by the single CXCR5+ and 
PD-1+/Tfh cells that represented 27 and 20% of the memory CD4 
T cells, respectively (Figure 1E).
The estimation of frequencies of cells containing integrated 
HIV-1 DNA among the sorted blood (N = 12) and LN memory 
CD4 T-cell populations (N = 8) (Figure 1F) revealed no signifi-
cant differences among memory CD4 T cell populations isolated 
from blood and/or LN (P > 0.05) (Figure 1F). In particular, the 
frequency of blood CXCR3+ CD4 T cells containing integrated 
HIV-1 DNA reached 5,188 copies per million, 3,882 copies 
per million in cTfh cells, 4,765 copies per million in Th1-like 
cTfh cells, 1,732 copies per million CCR4+ CD4 T  cells, and 
3,965 copies per million in CCR4+CCR6+ subset of CD4 T cells 
(Figure  1F). Integrated HIV-1 DNA was detected at a mean 
frequency of 5,281 copies per million cells within LN PD-1+/
Tfh cells CD4 T  cells with no significant differences with the 
LN DN and single CXCR5 CD4 T-cell populations (P > 0.05) 
(Figure 1F).
We next evaluated the contribution of blood and LN CD4 
T-cell populations to the total pool of cells containing inte-
grated DNA within these compartments. The cumulative data 
indicated that blood CXCR3+ CD4 T cells contributed the most 
and represented about 40% of the blood reservoir containing 
integrated HIV DNA (Figure 1G). In the LN compartment, DN 
CD4 T-cell population contributed the most, reaching up to 48% 
of the LN reservoir containing integrated HIV DNA (P < 0.05) 
(Figure  1H). Finally, we evaluated the overall contribution of 
each sorted blood and LN CD4 T-cell population to the total pool 
of cells containing integrated HIV DNA within both blood and 
LN compartments in matched individuals (N = 3). The cumula-
tive data showed that the DN CD4 T-cell population obtained 
from LNs contributed the most and up to 58% to the total HIV 
integrated DNA reservoir from blood and LN compartments 
(Figure 1I).
hiV replication and Production of Blood 
and ln Memory cD4 T cell Populations
In order to estimate the frequencies of HIV-1-infected cells 
containing inducible replication competent virus in both blood 
and LN compartments, we performed a viral outgrowth assay 
(VOA) on each isolated blood and LN CD4 T cell population 
(Figure S3 in Supplementary Material). However, the limited 
number of cells available prevented us to perform the quan-
titative virus outgrowth assay (Q-VOA) under conventional 
experimental conditions, i.e., different cell dilutions and 
multiple replicates, necessary to generate the frequencies of 
cells containing replication competent and/or infectious virus 
within the different memory CD4 T-cell populations for each 
HIV-1-infected individual. Therefore, a conventional VOA was 
performed using four single replicate cell dilutions, i.e., 5 × 105, 
105, 2 × 104, and 4 × 103 cells for all the sorted blood chemokine 
expressing CD4 T-cell populations (N =  13) and three single 
replicate cell dilutions, i.e., 105, 2 ×  104, and 4 ×  103 cells for 
all the sorted LN CD4 T-cell populations sorted on the basis of 
CXCR5 and PD-1 expression (N = 11). All cell populations were 
stimulated with anti-CD3 and anti-CD28 monoclonal antibod-
ies (MAbs) and cultured with allogeneic CD8-depleted blood 
mononuclear cells isolated from HIV-uninfected individuals 
for 14  days (Figure S3 in Supplementary Material). The pres-
ence of HIV-1 RNA was assessed in the culture supernatants 
at day 14 as previously described (17). Both the proportion of 
positive wells and the levels of HIV-1 RNA were generated in 
the VOA using the highest common concentration of cells (105 
cells/condition), while the limiting dilution format was used to 
evaluate the frequencies of cells containing inducible replication 
competent virus as in previous studies (35). The frequencies of 
cells containing inducible replication competent virus assessed 
FigUre 1 | Quantification of HIV Integrated DNA in blood and lymph node memory CD4 T-cell populations (a) Representative flow cytometry profile of blood 
memory (CD45RA−) CD4 T-cell populations expressing chemokine receptors isolated from one representative aviremic long-term-treated HIV-1-infected individual. 
(B) Representative flow cytometry profile of lymph nodes (LN) memory (CD45RA−) CD4 T-cell populations expressing CXCR5 and/or PD-1 isolated from one 
aviremic HIV-1-infected long term-treated subject. (c) Representative flow cytometry profile of surface expression of CXCR5 on LN PD-1+ memory CD4 T cells 
isolated from one representative aviremic long-term-treated HIV-1-infected individual. (D) Frequency of chemokine receptor expressing blood memory (CD45RA−) 
CD4 T cells isolated from aviremic long-term-treated HIV-1-infected individuals (N = 12). (e) Frequency of CXCR5 and/or PD-1-expressing LN CD4 T cells isolated 
from aviremic long-term-treated HIV-1-infected individual (N = 8). (F) Frequency of cells containing integrated HIV DNA (copies per million cells) within chemokine 
receptor expressing blood (N = 12) and CXCR5 and/or PD-1 expressing LN (N = 8) memory CD4 T-cell populations. (g) Contribution of chemokine receptor 
expressing blood memory CD4 T-cell populations to the total pool of cells containing integrated HIV DNA in blood (N = 12). (h) Contribution of CXCR5 and/or PD-1 
expressing LN memory CD4 T-cell populations to the total pool of cells containing integrated HIV DNA in LN (N = 8). (i) Contribution of blood and LN memory CD4 
T-cell populations of matched individuals to the total body pool of cells containing integrated HIV DNA in blood and LN compartments (N = 3). HIV-infected 
individuals are color coded (D–i). Histograms correspond to mean of blood or lymph node CD4 T-cell population (D–i); red bars correspond to SEM (D–i). “X3” 
corresponds to blood CXCR3-expressing CD4 T cells; “R4” corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ corresponds to blood CCR4+CCR6+ CD4 
T cells; “X5” corresponds to blood CXCR5-expressing CD4 T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ CD4 T cells. “LN” corresponds to lymph 
node. Red stars indicate statistical significance (P < 0.05). Statistical significance (P-values) was obtained using one-way ANOVA (Kruskal–Wallis test) followed by 
Wilcoxon matched-pairs two-tailed signed rank test (D–i).
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by the detection of HIV RNA at day 14 in VOA supernatants was 
expressed as RNA-unit per million (RUPM) (32) (Figure S3 in 
Supplementary Material).
We first compared the proportion of HIV RNA positive wells 
at day 14 in the VOA culture supernatants of all blood (N = 13) 
and LN CD4 T-cell populations (N = 11) at the highest common 
FigUre 2 | HIV replication and production of blood and lymph node (LN) memory CD4 T cell populations. (a) Proportion of HIV RNA positive wells among blood 
(N = 13) and LN (N = 11) memory CD4 T-cell populations at day 14 of virus outgrowth assay (VOA). Wells with detectable HIV-1 RNA (≥20 HIV-1 RNA copies/mL) 
were referred to as HIV-1 RNA-positive wells. (B) Levels of HIV-1 RNA in blood (N = 13) and LN (N = 11) memory CD4 T cell populations at day 14 of VOA. 
Undetectable values were arbitrarily defined as 10 HIV-1 RNA copies/mL. HIV-infected individuals are color coded (C). “X3” corresponds to blood CXCR3-
expressing CD4 T cells; “R4” corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ corresponds to blood CCR4+CCR6+ CD4 T cells; “X5” corresponds to 
blood CXCR5-expressing CD4 T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ CD4 T cells. “LN” corresponds to lymph node. Red stars indicate 
statistical significance with in blood compartment (P < 0.05). Green stars indicate statistical significance within LN compartment (P < 0.05). Statistical significance 
(P-values) was either obtained using two-tailed Chi-square analysis for comparison of positive proportions (a) or using one-way ANOVA (Kruskal–Wallis test) 
followed by Wilcoxon matched-pairs two-tailed signed rank test (B).
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cell concentration (i.e., 105) (Figure 2A) (35). Of note, 6 individu-
als were matched for blood and LN. The data showed that wells 
containing LN PD-1+/Tfh CD4 T  cells were significantly more 
frequently scored positive (90% of positive wells, corresponding 
to 9 out of the 11 individuals tested) as compared to LN CXCR5+ 
and LN DN CD4 T  cell populations (P <  0.05) (Figure  2A), 
supporting previous observation (17). However, in blood, wells 
containing CXCR3-expressing CD4 T cells were more frequently 
scored positive (92% of positive wells, corresponding to 12 out of 
13 individuals tested) than any other blood CD4 T-cell popula-
tions (Figure 2A).
We next assessed the levels of HIV-1 RNA in culture super-
natants of all blood (N =  13) and LN (N =  11) CD4 T-cell 
populations at the highest common cell concentration (i.e., 
105) cells at day 0 and 14 (Figure 2B) (35). Of note, none of 
the culture supernatants collected at day 0 were positive for 
the detection of HIV-1 RNA (data not shown). Consistent with 
previous study (17), LN PD-1+/Tfh cell VOA culture super-
natants contained significantly higher levels of HIV-1 RNA 
than any other LN memory CD4 T-cell populations (P < 0.05) 
(Figure 2B).
However, in blood, CXCR3-expressing CD4 T  cells VOA 
culture supernatants contained higher levels of HIV-1 RNA than 
any other blood memory CD4 T-cell populations (except from 
cTfh cells; P = 0.08) (Figure 2B), suggesting that blood CXCR3-
expressing CD4 T cells of ART-treated aviremic HIV-1 infected 
individuals might be enriched in cells containing replication 
competent virus.
Blood cXcr3-expressing cD4 T cells of 
long-term-Treated aviremic hiV-1-
infected individuals are enriched in cells 
containing replication competent Virus
To address the issue of the average frequency of HIV-1-infected 
cells containing inducible replication competent virus for each 
memory CD4 T-cell population in blood and LN compartments, 
the data generated from the single replicate cell dilutions of blood 
and LN CD4 T-cell populations using the conventional VOA were 
pooled together such that each patient well at a particular tested 
concentration in the VOA now represented a replicate; mean fre-
quencies within the cohort were therefore then estimated using 
extreme limiting dilution assay (33) as previously described (17). 
The frequencies of HIV-1-infected cells containing inducible rep-
lication competent virus are expressed in average RNA-unit per 
million (RUPM) (32) (Figures 3A,B) and statistical significance 
was obtained following a pair-wise test performed using Extreme 
Limiting Dilution Assay (33). Consistent with previous study 
(17), LN PD-1+/Tfh cells were significantly enriched in cells 
containing replication competent virus reaching 23 cells per 
million (Figure 3B). Interestingly however, the results obtained 
from blood samples indicated that blood CXCR3-expressing CD4 
T cells but not CXCR5-expressing CD4 T cells were significantly 
enriched in cells containing inducible replication competent 
virus reaching about 13 cells per million (P < 0.05) (Figure 3A) 
while CXCR5-expressing CD4 T cells reached around 4 cells per 
million.
FigUre 3 | Blood CXCR3-expressing CD4 T cells of long-term-treated aviremic HIV-1-infected individuals are enriched in cells containing replication competent 
virus. (a) Estimated RNA-unit per million (RUPM) frequencies in chemokine receptor expressing blood memory CD4 T-cell populations (N = 13). (B) Estimated 
RUPM frequencies in CXCR5 and/or PD-1 expressing lymph node (LN) memory CD4 T-cell populations (N = 11). (c) Estimated contribution of blood memory CD4 
T-cell populations to the pool of cells containing replication competent virus in blood (N = 13). (D) Estimated contribution of LN memory CD4 T-cell populations to 
the pool of cells containing replication competent virus in LN compartment (N = 11). (e) Estimated contribution of blood and LN memory CD4 T-cell populations of 
matched individuals to the total pool of cells containing replication competent virus in blood and LN compartments (N = 6). Contribution of memory CD4 T-cell 
populations to the pool of cells containing replication competent virus was calculated as previously described (17). Histograms correspond to estimated mean  
(a–e) and red bars correspond to the lower and upper confidence interval at 0.95 (a–e). “X3” corresponds to blood CXCR3-expressing CD4 T cells; “R4” 
corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ corresponds to blood CCR4+CCR6+ CD4 T cells; “X5” corresponds to blood CXCR5-expressing CD4 
T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ CD4 T cells. “LN” corresponds to lymph node. Red stars indicate statistical significance (P < 0.05). 
Statistical significance (P-values) was either obtained using Extreme Limiting Dilution analysis (http://bioinf.wehi.edu.au/software/elda/) (a,B), by pairwise 
comparisons of proportion with FDR correction (multiple tests) (c,e) or by Fisher’s exact test for pairwise comparisons (D) (36).
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On the basis of the above data and since various CD4 T-cell 
populations may contribute to the total pool of cells containing 
replication competent virus within blood and LN compart-
ments, the assessment of the relative contribution of each CD4 
T cell population was then performed using (1) the frequency of 
each cell population in each compartment (blood and/or LN), 
(2) the estimated numbers of CD4 T  lymphocytes in different 
lymphoid organs (34), and (3) the estimated frequencies of cells 
containing inducible replication competent virus within each 
blood and LN memory CD4 T  cell population as previously 
described (17). The results indicated that in blood, the CXCR3-
expressing CD4 T cells contributed the most to the pool of cells 
containing inducible replication competent virus in blood and 
represented about 56% of the blood reservoir containing replica-
tion competent virus (P <  0.05) (Figure  3C). Consistent with 
previous study (17), LN PD-1+/Tfh cells contributed the most 
to the pool of cells containing inducible replication competent 
virus in LN (represented about 60%) (P < 0.05) (Figure 3D) and 
contributed the most to the pool of cells containing inducible 
replication competent virus in blood and LN (represented about 
58%) (P < 0.05) (Figure 3E).
Taken together, these data indicate that blood CXCR3-
expressing CD4 T cells isolated from ART-treated aviremic HIV-
1-infected individuals are enriched in cells containing inducible 
replication competent virus and contributed the most to the HIV 
reservoir in blood.
Blood cXcr3-expressing cD4 T cells  
of arT-Treated aviremic hiV-1-infected 
individuals represent the Major source  
of infectious hiV-1 in Blood
In order to determine whether the virus obtained in the VOA 
culture supernatants of blood memory CD4 T-cell populations 
was infectious, we performed an in vitro HIV-1 infection assay. 
For these purposes, day 14 VOA culture supernatants of the 
highest cell concentration (i.e., 5 × 105) were used to inoculate 
preactivated CD8-depleted blood mononuclear cells isolated 
from HIV negative individuals as previously described (17). 
Culture supernatants were collected at day 0 and 14 and assessed 
for the presence of HIV-1 RNA. Of note, none of the culture 
supernatants collected at day 0 had detectable levels of HIV-1 
FigUre 4 | Blood CXCR3+ CD4 T cells of antiretroviral therapy (ART)-treated aviremic HIV-1-infected individuals represent the major source of infectious HIV-1 in 
blood. (a) Proportion of HIV-1-infected individuals with detectable HIV-1 RNA (≥200 HIV-1 RNA copies/mL) in the in vitro HIV-1 infection assay. (B) Levels of HIV-1 
RNA in blood memory CD4 T cell populations at day 14 of in vitro HIV-1 infection assay (N = 13). (c) Correlation between HIV-1 RNA levels measured in VOA and  
in in vitro HIV-1 infection assay in supernatants of blood memory CD4 T-cell populations (N = 13). Undetectable values were arbitrarily defined as 100 HIV-1 RNA 
copies/mL (B,c). Each individual is uniquely color coded in (B). Each CD4 T-cell population is uniquely colored in (c). Histograms correspond to mean (a,B); red 
bars correspond to SEM (B). “X3” corresponds to blood CXCR3-expressing CD4 T cells; “R4” corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ 
corresponds to blood CCR4+CCR6+ CD4 T cells; “X5” corresponds to blood CXCR5-expressing CD4 T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ 
CD4 T cells. Red stars indicate statistical significance (P < 0.05) (a,B). Statistical significance (P-values) was either obtained using two-tailed Chi-square analysis  
for comparison of positive proportions (a) or using one-way ANOVA (Kruskal–Wallis test) followed by Wilcoxon matched-pairs two-tailed signed rank test (B) or 
Spearman rank test for correlation (c).
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RNA (data not shown). However, after 14 days of culture, HIV-1 
RNA was more frequently detected in culture supernatants of 
CXCR3-expressing CD4 T  cells (8 out of the 13 ART-treated 
aviremic HIV-1-infected individuals tested) as compared to any 
other blood CD4 T-cell populations (Figure  4A). In addition, 
the levels of HIV-1 RNA detected in culture supernatants of 
blood CXCR3-expressing CD4 T cells were significantly higher 
as compared to any other blood CD4 T-cell subsets (P < 0.05) 
(Figure  4B). Finally, we determined the relationship between 
HIV-1 RNA levels detected in the VOA and those detected in 
the in vitro HIV-1 infection assay. The results indicated a strong 
correlation between HIV-1 RNA levels detected in VOA culture 
supernatants and HIV-1 RNA levels detected in the in vitro HIV-1 
infection assay (r = 0.8175, P < 0.0001) (Figure 4C).
Taken together, these data suggest that blood CXCR3-
expressing CD4 T cells of ART-treated aviremic HIV-1-infected 
individuals represent the major source of infectious HIV-1 in 
blood.
Phylogenetic sequence analyses of the 
highly Variable envV1V4 region in sorted 
Blood and ln Memory cD4 T-cell 
Populations
In order to address the phylogenetic relationship between HIV 
sequences obtained from blood and LN CD4 T-cell populations, 
we sorted blood and LN CD4 T-cell populations of matched 
ART-treated HIV-infected individuals as previously mentioned 
and single genome sequencing of the highly variable region of 
the gp160 virus envelope, the EnvV1V4 region, was performed 
using next generation sequencing platform from PacBio Systems 
as previously described (37).
The phylogenetic analysis revealed that the sequences 
obtained from the individual #35 and #077 were monophyletic 
while those obtained from individual #094 were not (Figure 5A), 
indicating varying degree of virus diversity. In all three ART-
treated HIV-infected individuals tested, phylogenetic inference 
revealed that virus pools from any given cell population were 
closely related to the virus from all other cell fractions demon-
strating a lack of virus compartmentalization (Figure 5B).
PD-1 expression on Blood cXcr3-
expressing cD4 T cells Positively 
correlates with the levels of hiV-1 rna 
Produced in the VOa culture supernatants
Next, we explored whether specific parameters such as the level 
of T-cell activation (assessed by HLA-DR and Ki-67 expression), 
T-cell differentiation (assessed by CD45RA, CCR7 and/or CD27 
expression), HIV coreceptor (CCR5 and CXCR4) or restric-
tion factor (SAMHD1) expression may be associated with the 
increased frequency of cells containing replication competent 
virus within blood CXCR3-expressing CD4 T cells. To address 
this issue, the level of HLA-DR, Ki-67, CCR5, CXCR4, SAMHD1, 
CD45RA, CCR7, and CD27 were determined on the various 
blood CD4 T-cell populations of HIV-1-infected ART-treated 
individuals by flow cytometry (Figures 6A–F). The cumulative 
data indicated that blood CXCR3-expressing CD4 T cells were 
not significantly enriched in activated T cells expressing HLA-DR 
or Ki-67 (P > 0.05) (Figures 6A,B), in cells expressing the HIV 
FigUre 5 | Phylogenetic relationship of HIV-1 envelope sequences derived from CD4 T-cell populations. Sequences of the highly variable EnvV1V4 region (Hxb 
6540-7668) were derived from blood and LN memory CD4 T-cell populations isolated from aviremic-treated HIV-1-infected individuals (N = 3). Virus quasi-species 
were amplified and sequenced [single molecule, real-time (SMRT) method/PacBio Systems]. (a) Phylogenetic relationship of HIV-1 envelope sequences derived 
from CD4 T-cell populations (N = 3). The phylogenetic relationship was inferred by the Maximum Likelihood method based on the General Time Reversible 
substitution model (GTR + G). Each tree includes reference sequences from subtype B and non-B HIV-1-infected individuals. (B) Nucleotide variations observed 
within each blood and LN memory CD4 T-cell population estimated using the Gama distributed kimura-two-parameter. CD4 T-cell populations were color coded 
(a,B). dc corresponds to the laboratory isolate control used to monitor sequence diversity induced by the method. “X3” corresponds to blood CXCR3-expressing 
CD4 T cells; “R4” corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ corresponds to blood CCR4+CCR6+ CD4 T cells; “X5” corresponds to blood 
CXCR5-expressing CD4 T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ CD4 T cells. “LN” corresponds to lymph node.
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coreceptors CXCR4 or CCR5 (P > 0.05) (Figures 6C,D). In addi-
tion, blood CXCR3-expressing CD4 T cells were not significantly 
enriched in central memory (CCR7+CD27+) nor in transitional 
memory (CCR7−CD27+) CD4 T  cells (P >  0.05) (Figure  6F). 
Finally, blood CXCR3-expressing CD4 T  cells did not express 
significantly lower levels of the host restriction factor SAMHD1 
(P > 0.05) (Figure 6E).
Since, a recent study highlighted that blood CD32-expressing 
CD4 T cells were enriched in HIV-infected cells (12), therefore 
we assessed the level of CD32 expression on chemokine express-
ing CD4 T-cell populations (Figure  6G). The cumulative data 
indicated that blood CXCR3-expressing CD4 T  cells were not 
significantly enriched in cells expressing CD32 (P  >  0.05) 
(Figure 6G).
Finally, since PD-1 expression on CD4 T cells has been associ-
ated with increased frequencies of HIV-infected cells (16, 17), we 
next assessed the level of PD-1 expression on each blood memory 
CD4 T-cell population of ART-treated HIV-infected individuals. 
The cumulative data indicated that blood CXCR3-expressing 
CD4 T  cells were not significantly enriched in cells expressing 
PD-1 (P > 0.05) (Figure 6H), however, the frequency of PD-1 
expressing blood CXCR3-expressing CD4 T cells positively cor-
related with the levels of HIV-1 RNA produced in the VOA cul-
ture supernatants of CXCR3-expressing CD4 T cells (r = 0.628, 
P = 0.05) (Figure 6I), suggesting that PD-1+CXCR3+ CD4 T cells 
might be enriched in cells containing inducible replication com-
petent virus in blood.
ln PD-1 expressing cD4 T cells express 
high levels of cXcr3
In order to determine the potential origin of blood CXCR3-
expressing CD4 T  cells, the expression of CXCR3, CCR4 and/
or CCR6 was assessed on LN memory (CD45RA−) CD4 T-cell 
populations isolated from viremic untreated HIV-infected indi-
viduals (Figure 7). The data showed that all PD-1-expressing LN 
CD4 T-cell populations of viremic HIV-infected individuals were 
enriched in CXCR3+ CD4 T cells in comparison to CCR4+, single 
CCR6+, CCR4+CCR6+, and CCR4−CCR6− CD4 T cells (P < 0.05) 
(Figure 7). In contrast the PD-1-negative CD4 T-cell populations 
expressed either comparable levels of CXCR3 and CCR4 (single 
CXCR5 LN CD4 T cells; P > 0.05) or were dominated by CCR4-
expressing and CCR4−CCR6− CD4 T cells (DN LN CD4 T cells; 
P < 0.05) (Figure 7).
Taken together, these data suggest that CXCR3-expressing 
blood CD4 T cells may originate from LN PD-1+ CD4 T cells. 
However, further longitudinal analyses would be needed to sup-
port this hypothesis.
DiscUssiOn
One of the major barriers to HIV eradication is the presence 
of cells containing latent, transcriptionally silent, but inducible 
replication competent virus in ART-treated aviremic HIV-
infected individuals (4, 8, 38). Therefore, great effort was placed 
FigUre 6 | PD-1 expression on blood CXCR3+ CD4 T cells positively correlates with the levels of HIV-1 RNA produced in the virus outgrowth assay (VOA) culture 
supernatants. Percentage of expression of HLA-DR (a), Ki-67 (B), CXCR4 (c), CCR5 (D), SAMHD1 (e) on chemokine receptor expressing blood memory 
(CD45RA−) CD4 T-cell populations isolated from aviremic long-term-treated HIV-1-infected individuals (N = 10). (F) Differentiation profile of chemokine receptor 
expressing blood memory (CD45RA−) CD4 T-cell populations isolated from aviremic long-term-treated HIV-1-infected individuals (N = 10). Percentage of CD32+ 
(N = 7) (g) or PD-1+ (N = 10) (h) chemokine receptor expressing blood memory (CD45RA−) CD4 T-cell populations isolated from aviremic long-term-treated 
HIV-1-infected individuals. (i) Correlation between HIV-1 RNA levels detected in day 14 VOA supernatants of chemokine receptor expressing blood memory CD4 
T-cell populations and the percentage of PD-1-expressing CD4 T cells within each chemokine receptor expressing blood memory CD4 T-cell population. 
Undetectable values were arbitrarily defined as 10 HIV-1 RNA copies/mL (i). Red bars correspond to SEM (a–h). “X3” corresponds to blood CXCR3-expressing 
CD4 T cells; “R4” corresponds to blood CCR4-expressing CD4 T cells; R4+R6+ corresponds to blood CCR4+CCR6+ CD4 T cells; “X5” corresponds to blood 
CXCR5-expressing CD4 T cells; And X3+X5+ corresponds to blood CXCR3+CXCR5+ CD4 T cells. Each HIV-infected individual was color coded (a–h). Red stars 
indicate statistical significance (P < 0.05) (a–h). Statistical significance (P-values) was either obtained using one-way ANOVA (Kruskal–Wallis test) followed by 
Wilcoxon matched-pairs two-tailed signed rank test (a–h) or Spearman rank test for correlation (i).
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to characterize HIV-infected cells in blood and tissues (39). 
In this regard, we have recently shown that LN PD-1+/Tfh cells 
were enriched in cells containing inducible replication compe-
tent virus in ART-treated aviremic HIV-infected individuals 
(17), which is probably associated with the reduced capacity of 
CD8 T cells and cART to penetrate into germinal center (GC) 
areas (19, 40).
Since memory LN Tfh cells may egress from GCs and 
recirculate in blood (20), we hypothesized that the LN Tfh 
cell counterpart recirculating in blood might also be enriched 
in HIV-infected cells in ART-treated aviremic HIV-1-infected 
individuals. We therefore determined the frequency of cells 
containing integrated HIV-1 DNA or replication competent 
virus and their contribution to the HIV reservoir in blood and 
LN CD4 T-cell populations defined by chemokine receptor 
expression. Since the blood circulating Tfh counterpart has 
usually been identified on the basis of expression of chemokine 
receptors CXCR5 (22) and/or CXCR3 (20), we have first gated 
FigUre 7 | Chemokine receptor expression on lymph node memory CD4 T cell populations of viremic HIV-infected individuals. Percentage of chemokine receptor 
expression on lymph nodes (LNs) CD4 T-cell populations of viremic HIV-infected individuals (N = 9). Red bars correspond mean ± SEM. CD4 T-cell populations were 
color coded. Red stars indicate statistical significance (P < 0.05). Statistical significance (P-values) was either obtained using one-way ANOVA (Kruskal–Wallis test) 
followed by Wilcoxon matched-pairs two-tailed signed rank test.
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on and sorted for CXCR5 and/or CXCR3-expressing memory 
CD4 T-cell populations. In addition, cells expressing neither 
CXCR5 nor CXCR3, have previously been shown to be enriched 
in TH2-like (expressing CCR4+) and TH17-like (express-
ing CCR4 and CCR6) cells (41). Therefore, in addition to the 
CXCR5+ and/or CXCR3+ cells, we chose to sort for CCR4+ and 
CCR4+CCR6+ subsets amongst the CXCR3 and CXCR5 dual 
negative cells. Of note, the three other remaining populations, 
i.e., CXCR3+, CXCR5+, and CXCR3+CXCR5+ cell populations 
also contained cells expressing CCR4 and/or CCR6, but showed 
no significant differences between them. Therefore, in the pre-
sent study, we focused on and compared chemokine receptor 
expressing blood CD4 T-cell populations including CXCR5+ and 
CXCR5+CXCR3+ blood memory CD4 T cells, corresponding to 
“cTfh” (22, 23) and “Th1-like cTfh” (28) CD4 T cells, respectively, 
CXCR5−CXCR3−CCR4+, CXCR5−CXCR3−CCR4+CCR6+ blood 
memory CD4 T-cell populations and LN CD4 T-cell populations 
including LN PD-1+/Tfh CD4 T cells.
Interestingly, we did not observe significant differences in 
terms of frequencies of cells containing HIV-1 integrated DNA 
within and across blood and LN compartments. However, we 
showed that the blood CXCR3-expressing CD4 T cells contrib-
uted the most (up to 56%) to the HIV reservoir in blood, while 
DN LN CD4 T cells contributed the most to the HIV reservoir 
in LN.
We then evaluated and compared the capacity of blood and 
LN memory CD4 T-cell populations isolated from ART-treated 
aviremic HIV-1-infected individuals to support active virus 
replication and produce infectious viruses. In this context, we 
showed that, consistent with previous studies, LN PD-1+/Tfh cells 
were the largest source of inducible replication competent virus. 
Interestingly, we showed that, in blood, CXCR3-expressing CD4 
T cells but not CXCR5-expressing CD4 T cells were enriched in 
inducible replication competent and infectious virus and contrib-
uted the most to the replication competent reservoir in blood.
Unfortunately, the results obtained using the VOA assay 
did not allow to determine whether CXCR3-expressing CD4 
T cells contained more cells with intact provirus or whether the 
intact provirus was more easily inducible in CXCR3-expressing 
CD4 T cells as compared to other cell populations. One way to 
address this issue would be to perform full length sequencing of 
HIV provirus and to determine HIV provirus integration sites 
within each CD4 T-cell populations isolated from blood and LN 
compartments. Interestingly, the recent study by Lee et al. high-
lighted the presence of higher proportion of intact proviruses 
within blood type 1 helper (Th1) CD4 T cells (42). Since, blood 
CXCR3-expressing CD4 T  cells are usually enriched in cells 
harboring Th1 functions (41, 43, 44), it is well possible that blood 
CXCR3-expressing CD4 T cells would also be enriched in cells 
containing a higher proportion of intact provirus. Full length 
sequencing of HIV provirus and HIV integration site determi-
nation would also help to determine whether the accumulation 
of replication competent virus within one particular subset is 
associated with homeostatic T-cell proliferation or with a higher 
infection rate of blood CXCR3-expressing CD4 T-cell precursor. 
Indeed, recent studies have highlighted the role of homeostatic 
clonal expansion of blood HIV-infected memory CD4 T cells in 
HIV persistence (42, 45). Notably, Lee et al. also suggested that 
Th1  cells containing intact provirus may have accumulated in 
blood through clonal expansion (42).
Furthermore, various other parameters including epigenetic 
modifications such as DNA methylation of HIV gene promot-
ers or HIV provirus integration site may also potentially 
contribute to explain the relative lack of inducibility of cells 
containing intact proviruses (46, 47). In this regard, recent 
integration site analyses performed on blood CD4 T  cells of 
14
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treated HIV-infected patients demonstrated that intact HIV 
provirus may be enriched in transcriptionally silent parts of 
the genome, supporting the relative difficulty to reactivate 
HIV replication by VOA (46). Therefore, additional studies 
would be needed to determine the potential mechanism by 
which HIV-infected cells accumulate within blood CXCR3-
expressing CD4 T cells.
To determine the potential origin of blood CXCR3-expressing 
memory CD4 T cells containing replication competent virus, we 
performed proviral sequencing of EnvV1V4 region amplified 
from CD4 T-cell populations isolated from blood and LN com-
partments. The results obtained indicated that proviral sequences 
amplified from blood and LN CD4 T-cell populations were inter-
mingled with each other without any indication of compartmen-
talization. Therefore, these results although limited to certain cell 
populations indicated that the virus was highly related between 
the different cell populations, suggesting dynamic interchanges 
between the two compartments.
We then conducted a series of experiments to determine the 
potential parameters associated with the enrichment of cells 
containing replication competent virus within blood CXCR3-
expressing CD4 T cells. Notably, blood CXCR3-expressing CD4 
T cells did not express significantly higher levels of HIV corecep-
tors CCR5 and/or CXCR4, were not significantly more activated 
or did not express significantly lower levels of SAMHD1 restric-
tion factor as compared to the other blood chemokine receptor 
expressing CD4 T  cells. In addition, blood CXCR3-expressing 
CD4 T cells did not express significantly higher levels of CD32 or 
PD-1, however, the level of PD-1 expression on blood CXCR3-
expressing CD4 T cells directly correlated with the level of HIV 
RNA produced in the VOA supernatants suggesting that blood 
CXCR3-expressing CD4 T cells containing replication competent 
virus might express PD-1.
We then hypothesized that blood CXCR3-expressing CD4 
T  cells containing replication competent virus might have 
originated from HIV-infected LN CD4 T cells, that would have 
been infected during the viremic phase and would recirculate in 
blood after treatment initiation. Indeed the low state of activa-
tion and cell cycle progression of CXCR3-expressing memory 
CD4 T  cells as assessed by the levels of HLA-DR and Ki-67 
expression, respectively, also suggests that they may represent 
those cells that may have exited the tissue sites where prior virus 
replication may have taken place. Therefore, in order to address 
the origin of these cells, we assessed the chemokine receptor 
expression on various LN memory CD4 T  cells defined by 
CXCR5 and PD-1 expression isolated from untreated viremic 
HIV-infected individuals. Even though the analysis was cross-
sectional and not longitudinal, the results obtained indicated 
that CXCR3 is the most dominant chemokine receptor 
expressed on PD-1+ CD4 T cells including Tfh cells in viremic 
HIV-infected individuals whereas PD-1-negative CD4 T-cell 
populations, i.e., DN and single CXCR5 CD4 T-cell popula-
tions expressed either comparable levels of CXCR3 and CCR4 
or expressed higher levels of CCR4. It is therefore possible that 
HIV-infected CXCR3-expressing CD4 T  cells may originate 
from HIV-infected PD-1+CXCR3+ LN CD4 T cells in general 
and from Tfh cells in particular. Indeed, it has been clearly estab-
lished that LN GC Tfh cells downregulate CXCR5 expression in 
order to egress from the B cell follicle post-GC response (48, 
49). However, longitudinal assessment of chemokine receptor 
expression on LN Tfh cells from the viremic phase of infection 
till the control of infection post-ART treatment may provide 
further evidence for the chemokine receptors that are retained 
on these cells to orchestrate further migration from tissues and 
recirculation in blood.
Taken together, our data highlight the heterogeneity in 
the CD4 T-cell populations harboring cells containing induc-
ible replication competent virus in blood and LNs of aviremic 
ART-treated HIV-infected individuals. In particular, we show 
that blood CXCR3-expressing CD4 T  cells but not CXCR5-
expressing CD4 T cells were enriched in inducible replication 
competent virus and contributed the most to the replication 
competent reservoir in blood. However, additional studies 
would be needed to determine their potential origins and the 
mechanism by which HIV-infected cells accumulated within 
this particular subset.
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